1. Home
  2. RNAZ vs LZM.WS Comparison

RNAZ vs LZM.WS Comparison

Compare RNAZ & LZM.WS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

SELL

Current Price

$1.40

Market Cap

27.9M

Sector

Health Care

ML Signal

SELL

LZM.WS

Lifezone Metals Limited Warrants

N/A

Current Price

$0.40

Market Cap

32.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
RNAZ
LZM.WS
Founded
2016
N/A
Country
United States
Isle of Man
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
32.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
RNAZ
LZM.WS
Price
$1.40
$0.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.7K
★ 27.3K
Earning Date
08-14-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.36
52 Week High
$12.60
$0.40

Technical Indicators

Market Signals
Indicator
RNAZ
LZM.WS
Relative Strength Index (RSI) 31.10 N/A
Support Level N/A N/A
Resistance Level $1.93 N/A
Average True Range (ATR) 0.15 0.00
MACD -0.02 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
RNAZ
LZM.WS

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: